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ABSTRACT
Objectives: The aim of the study was to check whether the number of fulfilled diagnostic criteria of gestational diabetes 
mellitus (GDM) had any association with patients’ characteristics and pregnancy outcomes. 
Material and methods: A total of 756 women with single pregnancies and GDM who gave birth at the 2nd Department of 
Obstetrics and Gynecology of the Medical University of Warsaw between 01.2013–12.2016 were included in a retrospec-
tive analysis. Patients were divided into 2 groups: A — 499 patients diagnosed with GDM on the basis of one diagnostic 
criterion, B — 257 patients diagnosed with GDM on the basis of more than one diagnostic criterion. 
Results: Patients from group A had lower pre-pregnancy BMI than those from group B (median 24.9 kg/m2 vs. 26.5 kg/m2, 
p = 0.0003). Women from group A were less frequently treated with insulin than women from group B (19.1% vs. 32.7%; 
p = 0.00002). Group A had lower median OGTT levels than group B (85.9 mg/dL vs. 94.1 mg/dL, p = 0.0001; 160.2 mg/dL 
vs. 197.6 mg/dL, p = 0.0001; 144.8 mg/dL vs. 167.0 mg/dL, p = 0.0001; respectively). Moreover, in group B the average week 
of labor was earlier than in group A (mean 38.1 and 38.5 weeks of gestation, p = 0.0006). 
Conclusions: Patients who fulfilled more than one diagnostic criterion for GDM may have worse pregnancy outcome. 
We think that a number of fulfilled diagnostic criteria for GDM may be an important risk factor for insulin therapy during 
pregnancy and earlier gestational age at delivery.
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INTRODUCTION
Gestational diabetes mellitus (GDM) used to be defined 
as glucose tolerance disturbance of any degree (abnormal 
fasting glycemia, glucose intolerance, or diabetes) with on-
set or first recognition during pregnancy [1]. This population 
might have included women who had been diabetic, yet 
undiagnosed before becoming pregnant. According to the 
newest American Diabetes Association (ADA) guidelines of 
2017, GDM is diabetes that is first diagnosed in the second 
or third trimester of pregnancy and is rather not preexisting 
type 1 or type 2 diabetes [2].
No unified diagnostic criteria or procedures had been 
available for GDM for many years. The results of the Hyper-
glycemia and Adverse Pregnancy Outcome (HAPO) study 
were published in 2008 and they attempted to adjust the 
diagnostic criteria of GDM so as to ensure possibly best 
identification of women at highest risk of complications 
[3]. On the basis of these results, new diagnostic criteria of 
GDM were adopted by most (67.9%) scientific associations 
in Europe [4].
The GDM criteria as proposed by HAPO study authors 
[3] are characterized by lowered threshold values and/or 
allow for GDM diagnosis being made upon a lower number 
of diagnostic criteria as compared to earlier recommenda-
tions from scientific associations. This results in increased 
GDM diagnosis rates [5–8]. On one hand, this may lead to 
382
Ginekologia Polska 2018, vol. 89, no. 7
www. journals.viamedica.pl/ginekologia_polska
the disorder being over diagnosed while, on the other, re-
sulting in a higher number of patients in need who receive 
specialist diabetes care. 
Due to the change in the definition and the diagnostic 
criteria of GDM it is difficult to assess its global prevalence; 
however, it is estimated that 10–25% of all pregnant mothers 
worldwide [9] and 5.4% of pregnant mothers in Europe [10] 
either develop GDM or suffer from previously undiagnosed 
pre-gestational diabetes.
GDM increases the risk of neonatal complications in-
cluding macrosomia, birth weight above the 90th percentile 
(large for gestational age, LGA), hypoglycemia, hyperbili-
rubinemia, polycythemia, respiratory disorders, shoulder 
dystocia, as well as the risk of obesity and metabolic syn-
drome in adulthood. In mothers, GDM is associated with 
an increased risk of GDM in subsequent pregnancies and 
type 2 diabetes mellitus thereafter.
Objectives
In the face of these changes, a criterion is needed for 
identification the patients with the likelihood of more severe 
GDM requiring more medical care. Due to the fact that every 
patient with GDM had undergone a 75 g oral glucose toler-
ance test (OGTT), a decision was made to check whether the 
number of GDM diagnostic criteria associated with the test 
had any influence on the natural history of pregnancy, the 
delivery, and post-partum neonatal health.
MATERIAL AND METHODS
A total of 756 women with single pregnancies and di-
agnosis of GDM who gave birth at the 2nd Department 
of Obstetrics and Gynecology of the Medical University 
of Warsaw between 01.01.2013 and 31.12.2016 were in-
cluded in a retrospective analysis. GDM was diagnosed in 
accordance with relevant Polish Gynecological Society (PTG) 
guidelines on the basis of 75 g oral glucose tolerance test 
results [11, 12]. 
The conditions of the 75 g OGTT were as follows: the 
test was performed after nocturnal sleep, 8–14 hours after 
the last meal; subjects had to receive not less than 150 g of 
carbohydrates daily for 3 days before the test; the subjects 
were drinking 75 g of glucose dissolved in 250–300 mL of 
water within 5 minutes. During the test, the subjects were 
resting; they did not have any meals or smoke tobacco 
during that period. The tests were not performed during 
72 hours after antenatal steroid treatment in threatened pre-
term delivery or during intravenous treatment with beta-mi-
metics. Blood samples were collected in fasting condition 
as well as 1 and 2 hours after ingestion of glucose solution 
[11, 12]. Quantitative determination of glucose in venous 
blood was carried out by means of ultraviolet photometry 
using hexokinase-catalyzed enzymatic reactions [13].
Preliminary determinations of glucose levels were 
carried out at the first prenatal visit at the beginning of 
pregnancy so as to diagnose any potentially previously 
undiagnosed disturbances in carbohydrate metabolism. If 
no abnormal fasting blood glucose levels were observed in 
a risk factor-free patient, the diagnostic test was performed 
between gestation weeks 24 and 28, or earlier if symptoms 
suggestive of GDM had been observed. Diagnostic exami-
nation performed between gestation weeks 24 and 28 was 
a single-level determination consisting of the administration 
of the 75 g OGTT [12]. In women with GDM risk factors, 75 g 
OGTT was performed already during the first trimester. Ac-
cording to PTG, GDM risk factors include BMI ≥ 30kg/m2 and 
the history of any carbohydrate metabolism disturbances 
[12]. According to the Polish Diabetes Association (PTD) 
risk factors of in-pregnancy diabetes include age above 
35 years, history of giving birth to babies with birth weights 
of > 4000 g or with congenital defects, history of intrauterine 
fetal demise, arterial hypertension, overweight or obesity 
status, family history of type 2 diabetes mellitus, history 
of GDM in previous pregnancies, multiparity, or polycystic 
ovary syndrome [14]. If normal results of 75 g OGTT were 
obtained in this group during the first trimester, the test was 
repeated between weeks 24 and 28.
In June 2014, Polish diagnostic criteria of diabetes were 
changed to reflect the 2013 WHO guidelines [12, 15] based 
on the HAPO study results [3]. According to these guidelines, 
the pregnant patient was qualified for diagnostic examina-
tion between gestation weeks 24 and 28, if her fasting blood 
glucose level was < 92 mg/dL. When the blood glucose 
level was in the range of 92–125 mg/dL, 75 g OGTT was 
carried out immediately. When the fasting blood glucose 
level was ≥ 126 mg/dL, the measurement was repeated. In 
case of a repeated result of ≥ 126 mg/dL, the patient was 
diagnosed with GDM and urgently referred to a clinic of 
a higher referral order. These patients were not included in 
the analysis. If a result of < 126 mg/dL was obtained in the 
second measurement, 75 g OGTT was performed. In cases 
of random glycemia of ≥ 200 mg/dL, patients were urgently 
referred to a clinic of a higher referral order without the 75 g 
OGTT being performed. These patients were not included 
in the analysis.
Patients included in the analysis met one of the follow-
ing GDM diagnostic criterion: fasting blood glucose level 
of 92–125 mg/dL; 75 g OGTT 1-hour blood glucose level 
of  ≥ 180 mg/dL; 75 g OGTT 2-hour blood glucose level 
of 153–200  mg/dL [12, 15]. According to this diagnostic 
regimen, a total of 417 patients in whom 75 g OGTT was 
performed after June 2014, were diagnosed with GDM.
According to the previous PTG recommendations, the 
diagnostic criteria of GDM as determined by 75  g OGTT 
were as follows: fasting blood glucose level of  ≥ 100 mg/dL, 
383
Julia Zaręba-Szczudlik et al., The numer of GDM criteria predict the perinatal outcome
www. journals.viamedica.pl/ginekologia_polska
75 g OGTT 1-hour blood glucose level of  ≥ 180 mg/dL, and 
75 g OGTT 2-hour blood glucose level of ≥ 140 mg/dL [11]. 
A total of 339 patients in whom 75 g OGTT was performed 
by June 2014 were diagnosed with GDM according to this 
diagnostic regimen.
After the diagnosis of GDM, the management of pregnant 
patients consisted of diabetic diet and moderate, regular 
physical exercise. Pregnant patients performed self-assess-
ments with glucometer at least 4 times daily (when fasting 
and 1 hour after each main meal). Target self-assessment 
levels were 60–95 mg/dL for the fasting measurements 
and < 120 mg/dL for 1-hour postprandial measurements 
[11]. If the blood glucose levels could not be normalized by 
appropriate dietary management, insulin therapy was initi-
ated at doses being adjusted individually to patients’ blood 
glucose levels. Human insulins approved for use in pregnant 
women as well as rapid-acting insulin analogs were used. 
Patients were divided into 2 groups depending on the 
number of 75 g OGTT result abnormalities. Group A con-
sisted of 499 patients, in whom GDM was diagnosed on the 
basis of one diagnostic criterion,, while group B consisted of 
257 patients, in whom GDM was diagnosed on the basis of 
more than one diagnostic criterion. Of these, 205 patients 
met two diagnostic criteria, while 52 patients met all three 
diagnostic criteria of GDM (Tab. 1).
Both groups were compared in terms of socioeconomic 
data (age, urban vs. non-urban residence status, education, 
employment status, marital status), obstetric history (par-
ity, number of vaginal deliveries, history of cesarean sec-
tions, miscarriage, delivery of the baby with birth weight 
of > 4000 g) as well as anthropometric data (pre-gestational 
BMI, pregnancy weight gain).
With regard to the natural history of pregnancy, the 
compared variables included the week at which the patients 
were diagnosed with diabetes, blood glucose levels as meas-
ured in 75 g OGTT, the percentage of patients receiving in-
sulin treatment, the percentage of patients diagnosed with 
pre-pregnancy hypertension (PPH) and pregnancy-induced 
hypertension (PIH). The course of pregnancy was compared 
including the week of delivery, the percentage of preterm 
births, the method of delivery, and the percentage of pa-
tients, who had experienced peripartum complications 
(perineal or cervical tears).
The groups were also compared in terms of neona-
tal status assessed using the Apgar score 1 minute and 
5 minutes after birth, the percentage of neonates with birth 
weights above the 90th percentile (large for gestational age, 
LGA) and below the 10th percentile (small for gestational 
age, SGA) of the overall population [16], the percentage 
of neonates with hypoglycemia (defined as blood glucose 
level of < 40 mg/dL), hyperbilirubinemia (defined as serum 
blood bilirubin concentration of > 12 mg/dL), hypoxia, and 
peripartum injuries. Moreover, groups were compared in 
terms of the incidence of intraventricular hemorrhage in 
neonates, respiratory problems: either mild (i.e. resolving 
upon passive oxygen therapy), moderate (i.e. treated by 
continuous positive airway pressure), or severe (i.e. treated 
by mechanical ventilation), as well as of the percentage of 
neonates born with congenital defects and the percentage 
of intra-uterine fetal demise and peripartum death cases.
One-factor analysis was performed with the global sig-
nificance level of 0.05. Bonferroni correction for multiple 
testing was applied for the significance levels in individual 
tests, leading to final down-rounded value of 0.001. In ad-
dition, the impact of GDM severity on the frequency of 
preterm deliveries was tested with the standard statistical 
significance level of 0.05. Variables were compared by means 
of Student’s t-test, Mann-Whitney’s U-test, and chi-squared 
test. No differences were observed with regard to the impact 
of old and new GDM diagnostic guidelines on the obtained 
results.
The study protocol was approved by the Bioethics Com-
mittee of the Medical University of Warsaw. 
RESULTS
Maternal characteristics is presented in Table 2. The 
study groups did not differ in terms of maternal age, socio-
economic background, and obstetric history. The majority 
Table 1. Grouping strategies for GDM patients based on 75 g OGTT
GROUP A
n = 499
GROUP B
n = 257
One criterium Two criteria n = 205
Three criteria
n = 52
Fasting glucose level ↑ N N ↑ N ↑ ↑
1 h glucose level N ↑ N ↑ ↑ N ↑
2 h glucose level N N ↑ N ↑ ↑ ↑
Group A — GDM patients with one abnormal value on the 75 g OGTT; Group B — GDM diagnosed by two or three abnormal values on the 75g OGTT; ↑ — elevated 
glucose values that meet or exceed the GDM diagnostic criteria; N — normal glucose value; GDM — gestational diabetes mellitus; 75 g OGTT — 75 g oral glucose 
tolerance test
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of patients were married, multiparous, with higher edu-
cational background as well as positive employment and 
urban residence status. The groups did not differ in the 
extent of pregnancy weight gain, albeit patients in group B 
were characterized by BMI values being significantly higher 
than those in group A (26.5 kg/m2 vs. 24.9 kg/m²). In both 
groups, patients were diagnosed with GDM at similar time 
points during gestation. In the 75 g OGTT blood glucose lev-
els in group B patients were significantly higher than those 
in group A; this pertained to both the fasting measure-
ments and to the measurements performed 1 and 2 hours 
after glucose administration (94.1 mg/dL vs. 85.9 mg/dL; 
197.6 mg/dL vs. 160.2 mg/dL; 167.0 mg/dL vs. 144.8 mg/dL, 
respectively). Insulin treatment was required to normalize 
blood glucose levels in group B patients significantly more 
often than in group A patients (32.7% vs. 19.1%). The length 
of pregnancy was significantly higher in group A patients 
as compared to group B patients (38.5 vs. 38.1 weeks), with 
the percentage of premature births being statistically higher 
in group B patients (13.6% vs. 7.2%). No differences were 
 Table 2. Maternal characteristic and delivery data
Variable [unit] Group Amean ± SD or n (%)
Group B 
mean ± SD or n (%) p
Age [years] 32.69 ± 4.73 32.96 ± 4.79 ns
Urban place of residence 404 (80.9%) 193 (75.1%) ns
Tertiary educational level 384 (76.9%) 181 (70.4%) ns
Employed 471 (94.4%) 237 (92.2%) ns
Married marital status 433 (86.8%) 210 (81.7%) ns
Multiparas 250 (50.1%) 147 (57.2%) ns
History of vaginal delivery 194 (38.9%) 96 (37.4%) ns
1 140 (28.1%) 67 (26.1%) ns
> 1 54 (10.8%) 29 (11.3%) ns
History of ceasarian section 68 (13.6%) 61 (23.7%) ns
History of miscarrage 124 (24.8%) 72 (28%) ns
History of macrosomia 31 (6.2%) 28 (10,8%) ns
Pre-pregnancy BMI [kg/m²] 24.93 ± 4.87 26.45 ± 5.7 < 0.0003
Gestational weight gain [kg] 9.46 ± 5.84 9.23 ± 6.4 ns
GA at diagnosis of GDM [weeks] 23.09 ± 7.38 23.03 ± 7.38 ns
75 g OGTT glucose level [mg/dL]
FGL 85.93 ± 10.52 94.07 ± 16.46 < 0.0001
1 h 160.22 ± 27.96 197.57 ± 26.17 < 0.0001
2 h 144.78 ± 25.08 167.02 ± 35.1 < 0.0001
GDMG2 95 (19.1%) 84 (32.7%) 0.00002
PPH 42 (8.4%) 29 (11.3%) ns
PIH 25 (5.0%) 20 (7.8%) ns
GA at delivery [weeks] 38.5 ±1.4 38.1 ± 1.9 0.0006
Preterm delivery 36 (7.2%) 35 (13.6%) 0.004
Vaginal delivery 310 (62.1%) 142 (55.3%) ns
Operative vaginal delivery 13 (2.6%) 8 (3.1%) ns
Maternal injury 44 (8.8%) 18 (7%) ns
Cervical laceration 33 (6.6%) 16 (6.2%) ns
Perineal tears 11 (2.2%) 2 (0.78%) ns
1st degree 6 (1.2%) 2 (0.78%) ns
2nd degree 2 (0.4%) 0 ns
3rd degree 3 (0.6%) 0 ns
History of macrosomia — birth weight > 4000g; GA — gestational age; OGTT — oral glucose tolerance test; FGL — fasting glucose level; GDMG1 — diet controlled 
gestational diabetes mellitus; PPH — pre-pregnancy hypertension; PIH — pregnancy induced hypertension, and
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observed between the study groups with regard to the 
incidence of PIH, PPH, the method of the delivery or the 
incidence of perinatal injuries.  
Neonates born to mothers from both groups did not 
differ in their Apgar status, birth weight, or incidence of 
complications (Tab. 3).
DISCUSSION
Most patients in the analysis were diagnosed on the 
basis of a single GDM diagnostic criterion (499 vs. 256 pa-
tients), which was consistent with the results obtained by 
other authors [17–19].
As shown by the analyses of 100  g OGTT results, 
pre-gestational overweight status, advanced maternal age 
(> 35 years), multiparity, and history of GDM had an influence 
on the higher number of GDM diagnostic criteria being met 
by the patients [20–22]. In our study group, women who met 
more than one GDM diagnostic criterion were characterized 
by higher pre-gestational BMI values. Black et al. concluded 
that patients meeting only one postprandial criterion of 
GDM had lower pre-gestational BMIs than women meeting 
only the fasting criterion or women meeting both criteria 
[17]. As shown by numerous analyses, high pre-gestational 
BMI is associated with higher prevalence of macrosomia, 
LGA, PIH, and the need to deliver by cesarean section in both 
GDM-complicated and uncomplicated pregnancies [23–26]. 
According to Li et al., the risk of neonatal macrosomia is 
directly proportional to maternal blood glucose levels in 
gestation weeks 24–28 [27]. In our analysis, no significant 
difference in the prevalence of these complications could be 
observed despite significant differences in pre-gestational 
BMI values.
According to our results, women meeting more than one 
diagnostic criterion of GDM were characterized by higher 
blood glucose levels in all three measurements of the 75 g 
OGTT. Notably, the difference in the 1-hour postprandial 
results between the study groups was as high as 37 mg/dL. 
In addition, mean blood glucose levels measured during 
the 75 g OGTT in patients meeting more than 1 diagnostic 
criterion of GDM were always higher than the normal levels, 
 Table 3. Neonatal characteristic
Variable [unit] Group Amean ± SD or n (%)
Group B
mean ± SD or n (%) p
1st min Apgar score
≤ 7 15 (3%) 6 (2.4%) ns
8–10 483 (97%) 251 (97.7%) ns
5th min Apgar score
≤ 7 4 (0.8%) 2 (0.8%) ns
8–10 495 (99.2%) 255 (99.2%) ns
Birth weight [g] 3346.15 ± 516.32 3352.09 ± 595.31 ns
LGA 56 (11.2%) 35 (13.6%) ns
SGA 41 (8.2%) 17 (6.6%) ns
Perinatal injuries 9 (1.8%) 7 (2.7%) ns
Broken collarbone 3 (0.6%) 4 (1.6%) ns
Brachial plexus palsy 1 (0.2%) 0 ns
Skin abrasion 2 (0.4%) 1 (0.4%) ns
Subdural hematoma 1 (0.2%) 1 (0.4%) ns
IVH 3 (0.6%) 2 (0.8%) ns
Respiratory disorder 37 (7,4%) 28 (10.1%) ns
Mild 19 (3.8%) 17 (6.6%) ns
Moderate 14 (2.8%) 9 (3.5%) ns
Severe 4 (0.8%) 0 ns
Hypoglycemia 30 (6%) 22 (8.6%) ns
Hyperbilirubinemia 155 (31.1%) 96 (37.4%) ns
Congenital defects 30 (6%) 13 (5.1%) ns
Perinatal hypoxia 1 (0.2%) 3 (1.2%) ns
Stillbirth 1 (0.2%) 0 ns
LGA — large for gestational age; SGA — small for gestational age; IVH — intraventricular hemorrhage 
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while mean blood glucose levels measured during the 75 g 
OGTT in patients meeting just 1 criterion were within the 
normal limits. As shown by the HAPO study, the higher the 
maternal glucose levels, the higher the risk of GDM; the 
phenomenon is continuous in nature [3]. 
According to other authors, high blood glucose levels 
measured 1 hour after exposure in the 75 g OGTT are as-
sociated with higher risks of insulin therapy being required 
[28, 29]. As concluded by Mirta et al., blood glucose levels 
of ≥ 173.6 mg/dL as measured 1 hour after exposure in the 
75 g OGTT were characterized by the sensitivity of 100% and 
specificity of 73% as predictors of insulin therapy require-
ment [29]. In our study women meeting more than one 
diagnostic criterion more often required insulin therapy to 
achieve normal blood glucose levels.
According to the results of our study, women who met 
more than one diagnostic criterion of GDM delivered their 
babies significantly earlier which might be related to the 
practice of earlier induction of labor in GDMG2 pregnancies; 
however, a higher incidence of deliveries before gestation 
week 37 was also observed. Other authors also confirm that 
meeting more than 1 criterion of GDM is associated with 
higher risk of preterm delivery [17, 18].
According to the worldwide literature data, the increase 
in the number of GDM diagnostic criteria being met is as-
sociated with an increase in the risk of GDM-related obstetric 
and neonatal complications [17, 18], with the nature of these 
complications depending on the GDM “subtype” defined on 
the basis of whether the fasting or the postprandial criterion 
had been met [17]. LGA and shoulder dystocia are associ-
ated with the fasting diagnostic criterion while preterm 
delivery, PIH, and hyperbilirubinemia are associated with 
the postprandial criteria [17]. 
Other authors reported that, the higher number of di-
agnostic criteria met in the 100 g OGTT, the more frequent 
preterm delivery, PIH and pre-eclampsia, vaginal operative 
delivery, LGA, shoulder dystocia, and elevated umbilical 
blood levels of peptide C [20–22]. On the other hand, Kosus 
et al. were unable to identify any correlation between the 
number of diagnostic criteria being met in the 100 g OGTT 
and the neonatal birth weight [30].
In our study, no significant differences were observed 
between the study groups with regard to the incidence of 
peripartum complications in mothers or to the incidence of 
post-partum complications in the neonates, which might have 
been due to early detection of GDM and initiation of exten-
sive care by diabetologist and appropriate treatment during 
the pregnancy. Appropriate initiation of anti-GDM treatment 
prevents the development of complications [3, 31, 32].
In our study, high percentage of children with congenital 
defects was observed in both study groups. However, our 
department is a highly specialized clinic admitting patients 
with pregnancies complicated by congenital fetal defects 
and thus our study population is not representative of the 
overall population with this regard. 
Limitation of the study
The number of patients meeting all three diagnostic 
criteria was too small to establish a separate group includ-
ing these patient only, and therefore patients meeting all 
three GDM diagnostic criteria were included in a single 
study group with patients who met two criteria of GDM. 
The diagnostic criteria of GDM were changed in the course 
of the study, a
nd therefore different cut-off points were used for dif-
ferent patients in the same groups. 
CONCLUSIONS
To sum up, the number of GDM diagnostic criteria being 
met in 75 g OGTT may be considered a prognostic factor 
with regard to the natural history of GDM. More than one 
diagnostic criterion being met in 75 g OGTT may be used 
to identify a group of patients whose metabolic disorders 
might have been present before pregnancy and is associ-
ated with a higher risk of insulin therapy being initiated in 
pregnancy as well as with a higher risk of delivery before 
gestation week 37. As the result of appropriate GDM treat-
ment, the incidence of maternal and neonatal peripartum 
complications in pregnancies burdened with more than one 
GDM diagnostic criteria may not exceed that observed in 
the remaining patients.
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